141 related articles for article (PubMed ID: 11549414)
1. Effect of Clostridium perfringens epsilon toxin on MDCK cells.
Borrmann E; Günther H; Köhler H
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):85-92. PubMed ID: 11549414
[TBL] [Abstract][Full Text] [Related]
2. Evidence for cytoskeletal changes secondary to plasma membrane functional alterations in the in vitro cell response to Clostridium perfringens epsilon-toxin.
Donelli G; Fiorentini C; Matarrese P; Falzano L; Cardines R; Mastrantonio P; Payne DW; Titball RW
Comp Immunol Microbiol Infect Dis; 2003 May; 26(3):145-56. PubMed ID: 12581745
[TBL] [Abstract][Full Text] [Related]
3. Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells.
Petit L; Gibert M; Gourch A; Bens M; Vandewalle A; Popoff MR
Cell Microbiol; 2003 Mar; 5(3):155-64. PubMed ID: 12614459
[TBL] [Abstract][Full Text] [Related]
4. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.
Petit L; Gibert M; Gillet D; Laurent-Winter C; Boquet P; Popoff MR
J Bacteriol; 1997 Oct; 179(20):6480-7. PubMed ID: 9335299
[TBL] [Abstract][Full Text] [Related]
5. Morphological alterations in MDCK cells induced by exposure to Clostridium perfringens epsilon-toxin.
Hambrook JL; Lindsay CD; Hughes N
Biochem Soc Trans; 1995 Feb; 23(1):44S. PubMed ID: 7758757
[No Abstract] [Full Text] [Related]
6. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells.
Shortt SJ; Titball RW; Lindsay CD
Hum Exp Toxicol; 2000 Feb; 19(2):108-16. PubMed ID: 10773840
[TBL] [Abstract][Full Text] [Related]
7. Assembly of Clostridium perfringens epsilon-toxin on MDCK cell membrane.
Nagahama M; Ochi S; Sakurai J
J Nat Toxins; 1998 Oct; 7(3):291-302. PubMed ID: 9783265
[TBL] [Abstract][Full Text] [Related]
8. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers.
Petit L; Maier E; Gibert M; Popoff MR; Benz R
J Biol Chem; 2001 May; 276(19):15736-40. PubMed ID: 11278669
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin.
Payne DW; Williamson ED; Havard H; Modi N; Brown J
FEMS Microbiol Lett; 1994 Feb; 116(2):161-7. PubMed ID: 7512061
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Clostridium perfringens epsilon-toxin with biological and model membranes: A putative protein receptor in cells.
Manni MM; Sot J; Goñi FM
Biochim Biophys Acta; 2015 Mar; 1848(3):797-804. PubMed ID: 25485476
[TBL] [Abstract][Full Text] [Related]
11. Assessment of aspects of the toxicity of Clostridium perfringens epsilon-toxin using the MDCK cell line.
Lindsay CD
Hum Exp Toxicol; 1996 Nov; 15(11):904-8. PubMed ID: 8938486
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system.
Dorca-Arévalo J; Martín-Satué M; Blasi J
Vet Microbiol; 2012 May; 157(1-2):179-89. PubMed ID: 22264388
[TBL] [Abstract][Full Text] [Related]
13. Oligomer formation of Clostridium perfringens epsilon-toxin is induced by activation of neutral sphingomyelinase.
Takagishi T; Oda M; Takehara M; Kobayashi K; Nagahama M
Biochim Biophys Acta; 2016 Nov; 1858(11):2681-2688. PubMed ID: 27453200
[TBL] [Abstract][Full Text] [Related]
14. Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.
Hughes ML; Poon R; Adams V; Sayeed S; Saputo J; Uzal FA; McClane BA; Rood JI
J Bacteriol; 2007 Nov; 189(21):7531-8. PubMed ID: 17720791
[TBL] [Abstract][Full Text] [Related]
15. Resistance of ovine, caprine and bovine endothelial cells to Clostridium perfringens type D epsilon toxin in vitro.
Uzal FA; Rolfe BE; Smith NJ; Thomas AC; Kelly WR
Vet Res Commun; 1999 Aug; 23(5):275-84. PubMed ID: 10493114
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of different fluids for detection of Clostridium perfringens type D epsilon toxin in sheep with experimental enterotoxemia.
Layana JE; Fernandez Miyakawa ME; Uzal FA
Anaerobe; 2006 Aug; 12(4):204-6. PubMed ID: 16857397
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.
Robertson SL; Li J; Uzal FA; McClane BA
PLoS One; 2011; 6(7):e22053. PubMed ID: 21814565
[TBL] [Abstract][Full Text] [Related]
18. The development of tolerance to Clostridium perfringens type D epsilon-toxin in MDCK and G-402 cells.
Beal DR; Titball RW; Lindsay CD
Hum Exp Toxicol; 2003 Nov; 22(11):593-605. PubMed ID: 14686482
[TBL] [Abstract][Full Text] [Related]
19. Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.
Gil C; Dorca-Arévalo J; Blasi J
PLoS One; 2015; 10(10):e0140321. PubMed ID: 26452234
[TBL] [Abstract][Full Text] [Related]
20. Cellular vacuolation and mitochondrial-associated factors induced by Clostridium perfringens epsilon toxin detected using acoustic flow cytometry.
Ferrarezi MC; Curci VC; Cardoso TC
Anaerobe; 2013 Dec; 24():55-9. PubMed ID: 24076036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
